Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,042377-   
Low Rs590272-   
Sales per share (Unadj.) Rs298.6112.1-  
Earnings per share (Unadj.) Rs35.0-28.3-  
Cash flow per share (Unadj.) Rs49.4-23.4-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.188.0-  
Shares outstanding (eoy) m126.35168.78-   
Bonus / Rights / Conversions ESOS--  
Price / Sales ratio x2.72.9 94.4%   
Avg P/E ratio x23.3-11.5 -203.1%  
P/CF ratio (eoy) x16.5-13.9 -119.1%  
Price / Book Value ratio x3.33.7 89.6%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,10854,766 188.3%   
No. of employees `00013.44.3 313.1%   
Total wages/salary Rs m7,8743,437 229.1%   
Avg. sales/employee Rs Th2,807.04,409.0 63.7%   
Avg. wages/employee Rs Th585.8800.7 73.2%   
Avg. net profit/employee Rs Th329.0-1,111.0 -29.6%   
INCOME DATA
Net Sales Rs m37,73218,928 199.3%  
Other income Rs m577133 435.2%   
Total revenues Rs m38,30919,061 201.0%   
Gross profit Rs m6,901-3,280 -210.4%  
Depreciation Rs m1,824817 223.3%   
Interest Rs m189513 36.8%   
Profit before tax Rs m5,465-4,477 -122.1%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042280 372.6%   
Profit after tax Rs m4,422-4,769 -92.7%  
Gross profit margin %18.3-17.3 -105.5%  
Effective tax rate %19.1-6.2 -305.3%   
Net profit margin %11.7-25.2 -46.5%  
BALANCE SHEET DATA
Current assets Rs m23,77813,863 171.5%   
Current liabilities Rs m10,9757,800 140.7%   
Net working cap to sales %33.932.0 105.9%  
Current ratio x2.21.8 121.9%  
Inventory Days Days104111 93.5%  
Debtors Days Days66124 53.2%  
Net fixed assets Rs m20,3688,081 252.0%   
Share capital Rs m25388 287.6%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,22414,856 210.2%   
Long term debt Rs m1,4095,221 27.0%   
Total assets Rs m45,50728,065 162.1%  
Interest coverage x30.0-7.7 -387.5%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.80.7 122.9%   
Return on assets %10.1-15.2 -66.8%  
Return on equity %14.2-32.1 -44.1%  
Return on capital %17.3-19.8 -87.5%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,9231,616 304.7%  
From Investments Rs m-1,563-496 315.1%  
From Financial Activity Rs m-1,8324,738 -38.7%  
Net Cashflow Rs m1,5285,858 26.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.2 Rs / ZAR

Compare IPCA LABS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: PFIZER  JUBILANT PHARMOVA   PROCTER & GAMBLE HEALTH  NATCO PHARMA  SUN PHARMA  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

New Research: Our #1 Stock Pick Right Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


May 14, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - SUVEN LIFE SCIENCES COMPARISON

COMPARE IPCA LABS WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS